© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Anyone who has kept an eye on lipid research might remember the seismic shift that came with the move from animal-derived lecithins to defined synthetic phospholipids. In the early days, scientists would extract complex mixtures from natural sources, left to wrestle with impurity. Then came the breakthrough of synthetic methods, bringing molecules like 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, often dubbed DOPE. Through chemical synthesis, researchers began to command precision and repeatability in their work. Tracing this transformation untangles how lipid research gradually shed the fog of guesswork and embraced clarity. Without such progress, the industry wouldn’t have seen the rise of liposomal drug delivery or the tailored design of artificial membranes powering today’s biological studies.
DOPE holds a distinctive position in the world of membrane lipids. It provides a model molecule for understanding the behavior of amphiphiles in aqueous environments. Unlike some phospholipids that naturally form bilayers, DOPE draws interest because of its spontaneous tendency to form non-lamellar structures under physiological conditions. Those with experience in liposome preparation or membrane fusion studies know how crucial it is to choose the right lipid. Selecting DOPE often means a willingness to invite the unique, sometimes tricky, behaviors that push scientific boundaries.
Shaped by two oleoyl chains and a phosphoethanolamine head group, DOPE emerges as a light yellow, waxy solid at room temperature. Its molecular structure drives its preferences, pushing the molecule into inverted hexagonal phases. These non-bilayer arrangements fascinate researchers because they help explain how biological membranes undergo fusion—think of the merging of synaptic vesicles or viral envelopes—in living systems. In practical terms, its phase behavior means DOPE gives researchers tools to disrupt or stabilize membranes as needed, depending on the task at hand. With a molecular weight around 744 Da, and a hydrophilic head paired with a hydrophobic tail, it demonstrates classic amphipathic character. Solubility leans toward organic solvents, which makes the material amenable to the film hydration methods standard in lipid lab work.
Those purchasing DOPE in research quantities may come across labeling that includes an array of technical data—purity, source (synthetic or semi-synthetic), and, sometimes, the exact counterion present in the salt form. Laboratories often require confirmation of the sn-configuration, since stereochemistry drives membrane behavior. Tracking batch numbers and storage conditions on packaging remains essential, not as an exercise in bureaucracy, but because minor variations have derailed more than one experiment. It helps to recall the time a researcher shared their frustration at a conference, only to realize their samples had degraded after too many freeze-thaw cycles. This is a molecule that outsmarts complacency.
Chemical synthesis of DOPE typically follows a well-honed route: coupling of a protected glycerol backbone with activated oleic acid derivatives before introduction of phosphoethanolamine. Removal of protecting groups and careful purification steps guard stereochemistry and remove byproduct contaminants. Small slip-ups here—a poorly dried solvent, a misjudged reaction time—can send yields tumbling or taint the lipid with impurities that later skew data. Over the years, access to robust protocols improved the reproducibility of work across continents and disciplines, reducing barriers for new labs and opening up collaboration on an international scale.
One reason DOPE never fades from scientific conversation comes down to its chemical flexibility. Researchers readily modify the head group or acyl chains to produce derivatives tailored for specific projects. For instance, attaching fluorescent tags lets scientists track lipid movement in live cells. Pegylation, or linking polyethylene glycol chains, enables use in drug delivery, conferring stability in the bloodstream. Reactions targeting the ethanolamine moiety can alter charge or reactivity, giving rise to a robust toolkit for serious biochemical engineering. Those who have struggled with drug encapsulation or vesicle stability value these modification routes because they transform DOPE from a conceptual model into a practical, application-ready tool.
DOPE often travels under various aliases in catalogs and scientific writing. Names like 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine—or the abbreviated "DOPE"—fill methods sections in papers. Some refer to it as dioleoylphosphatidylethanolamine or just "phosphatidylethanolamine (PE, dioleoyl)". The maze of nomenclature frustrates those new to the field, especially as product lines expand to offer numerous tailored phospholipids. Mislabeling only takes a slip, so accuracy continues to matter for procurement and reproducibility.
Handling DOPE in the laboratory environment asks for attention beyond casual gloves and goggles. While deemed low in acute toxicity, inhalation of fine particulate or solvent fumes during preparation can present hazards. Working with organic solvents required for lipid dissolution can introduce fire and health risks, especially in busy laboratories. Relying on reliable chemical fume hoods and airtight containers keeps operations running smoothly and prevents contamination. As with all research materials, conscience guides responsible disposal, with both environmental and legal consequences for disregard. Routine staff training in safe lipid handling and emergency response helps avert costly, sometimes tragic, accidents.
One of the open secrets about DOPE is just how many corners of the life sciences it touches. In gene therapy and RNA delivery, formulating liposomes and lipid nanoparticles often begins with a DOPE-rich mixture. This is not a coincidence—its tendency to disrupt bilayer arrangements can actually facilitate endosomal escape, freeing therapeutic cargo inside target cells. In biophysical research, reconstituting proteins requires mimicking native membrane environments—again, DOPE proves invaluable. I’ve seen workshops where molecular biologists, chemists, and even physicists huddle around the spectrophotometer, debating the nuances of lipid ratios, knowing DOPE’s role can make or break the day’s experiment. These practical encounters with the molecule showcase why it refuses to fade from lab shelves.
DOPE reflects the evolution of research from curiosity-driven investigations to targeted applications. Its role in next-generation therapeutics makes it a regular feature at conferences exploring drug delivery, gene editing, and even vaccine formulations. Teams collaborate across silos, lending diverse expertise to projects revolving around new formulations and delivery systems. In my own experience, breakthroughs involving DOPE rarely occur in isolation—progress typically springs from informal conversations, troubleshooting setbacks, and the sharing of “failed” attempts. Commercial investment in synthetic biology and nanomedicine promises a continued surge in demand for high-purity, well-characterized DOPE and its derivatives.
Toxicology studies work as the backbone of responsible application, especially as DOPE migrates from bench to clinic. Results to date indicate a low acute toxicity profile, but as with all lipids entering living systems, subtler questions around chronic exposure, biodistribution, and immunogenicity remain. Peer-reviewed journals document rare incidences of immune activation or mild inflammatory responses tied to improperly formulated liposomal systems. It becomes important to contextualize these risks—no single ingredient tells the full safety story, but toxicologists keep DOPE under close watch as the field pushes for clinical adoption. Calls for more comprehensive, long-term animal and human studies reflect a commitment to safety and ethical science.
Looking ahead, the prospects for DOPE point upward as the boundaries between chemistry, biology, and medicine continue to blur. Investment in mRNA vaccines and precision therapeutics will likely boost demand for well-characterized phospholipids. Ongoing improvements in synthesis could deliver higher purity, custom modifications, and scalable routes beneficial for clinical translation. As new applications emerge—in diagnostics, bio-responsive materials, or targeted nanomedicine—researchers will continue to probe the quirks and capabilities of DOPE. Lessons from past decades echo here: success depends on not just innovation, but on a steady flow of communication and troubleshooting, where experience and vigilance matter as much as raw data. With continued investment in both talent and infrastructure, DOPE stands ready to anchor advances in life science research and patient care.
People in research labs often call 1,2-Dioleoyl-sn-Glycero-3-Phosphoethanolamine by the shorter name “DOPE.” It belongs to the group of phospholipids — the core stuff that forms the membranes of our cells. DOPE does a special job in both science and medicine due to its flexible structure and the way it interacts with other molecules. Scientists appreciate the way it makes things happen at a microscopic level, and that has a way of shaping results far beyond the test tube.
Drug delivery barely gets off the ground without liposomes and lipid nanoparticles. DOPE stands out as a flexible helper, giving drug carriers the ability to sneak past cell boundaries and deliver their cargo. Researchers use DOPE to help carry vaccines, especially gene-based ones. In my days as a grad student, we lost count of how many “failed” delivery systems needed a DOPE adjustment to make the whole design work. Its fluidity means it can fuse with cell membranes more easily, shuttling therapies or bits of RNA straight into cells. This has real-world value, especially in treatments that need precision deliveries — like cancer drugs or mRNA vaccines. The COVID-19 vaccine boom shined a light on how formulations like DOPE give new therapies a fighting chance inside the body.
Cell biologists use DOPE to study why certain membrane shapes fold, pinch, and change configuration. It’s not just academic curiosity. Real-life diseases result when cells struggle to keep their membranes in the right shape or allow the wrong materials to cross. By putting DOPE in the mix, you can tease out the reasons behind fusion events, such as viral entry or the way neurons send signals. In practical terms, better knowledge here leads to smarter treatments for viral infections, neurological diseases, and inherited disorders.
Diagnostics firms make use of DOPE, too. To set up reliable lab tests or develop biosensors, companies need stable yet responsive lipid films. DOPE keeps synthetic membranes pliable and promotes interactions, making test results sharper and more predictable. Years ago, while working in a clinical technology lab, I watched technicians debate the best “cocktail” for their assays, and adding DOPE always gave an edge when detecting tricky samples like viral particles or small proteins.
The flip side comes from how DOPE gets made. Producing high-purity phospholipids often pulls from animal or plant sources, which raises questions about sustainability and cost. Synthetic chemistry can help, but the process burns energy and raw materials. Looking down the road, sourcing DOPE without chewing up resources or relying on animal fats demands creativity. Fermentation-based production, using yeast or bacteria, holds promise. Some companies already explore these steps, hoping to meet demand while shrinking the environmental footprint.
Every time researchers choose DOPE, they bake flexibility into their designs. The molecule lets medicine and diagnostics slip past old limits. Anyone tracking advances in drug delivery or smarter diagnostic tools will see DOPE tagging along quietly in the background. Though you don't hear about it in the news nightly, this helper molecule quietly makes many cornerstones of modern medicine possible — and its story keeps evolving alongside the technology it supports.
Ask any scientist who’s spent time mixing lipids, and they’ll tell you that the phrase “soluble in water” gets thrown around a little too easily. 1,2-Dioleoyl-sn-Glycero-3-Phosphoethanolamine (often called DOPE by those who use it in research) brings this issue up front and center. Dumping DOPE straight into a beaker of water and stirring hard won’t do the trick. This stuff isn’t eager to disappear into water and vanish the way table salt does. Instead, DOPE leans heavily toward oils and sneaks into self-assembled structures instead of mingling freely in water.
The backbone of DOPE is built for oil. It has long, fatty tails that prefer the company of other hydrophobic molecules. Water, with its small polar molecules, doesn’t make an inviting home. I still remember struggling in the lab trying to dissolve it, thinking maybe heat or brute force could help, but the molecules just clumped together or floated on the surface. DOPE gravitates toward forming layers, such as bilayers or micelles, and sometimes tucks itself into vesicles if given the push with some sonication or extra chemistry.
Solubility isn’t just academic trivia. The way DOPE acts in water matters for fields like drug delivery, synthetic biology, and membrane research. Scientists trying to work with this lipid quickly realize they must plan ahead. The fat-loving tails drive DOPE together, so researchers use strategies—mixing with organic solvents, drying it down, then hydrating with water—to coax the lipid into forming tiny vesicles. These vesicles make great carriers for drugs or genetic material, showing promise in real-world treatments. But the insolubility means you can’t just dissolve DOPE, inject the solution, and call it a new medicine. Every step from preparation to delivery demands careful design.
People working with phospholipids like DOPE rely on practical tricks to get around its stubborn insolubility. Mixing DOPE with a sprinkle of ethanol or chloroform can create a temporary solution, then researchers evaporate the solvent, leaving behind a thin film. Hydrating this film with water, sometimes using a little ultrasonication, encourages the lipid to organize into vesicles. This method, known as the thin-film hydration technique, remains a scientific staple. Some labs add helper lipids (phosphatidylcholine or cholesterol) to tweak the final structure, steer stability, and mimic the complexity of natural membranes. Every step brings tradeoffs between simplicity, cost, and reliability.
Challenges extend beyond the lab. The pharmaceutical industry needs reproducible results and safe manufacturing methods. Relying on solvents or tough preparation steps can slow down progress. Newer approaches—like using microfluidic devices or freeze-drying pre-formed vesicles—show promise for scaling up. Researchers still chase better ways to harness lipids like DOPE without resorting to harsh chemicals. Open data helps by sharing what works and what falls short, cutting learning curves for newcomers.
Honest communication—sharing both the messy lab stories and the breakthroughs—matters as much as technical know-how. The lesson I learned with DOPE, standing at the bench and watching it stubbornly avoid dissolving, echoes through any research or manufacturing project. Respect for scientific evidence, plus a willingness to tinker and test assumptions, moves the work forward. Trust builds when teams collaborate, document well, and publish their ups and downs. It’s that combination of craft and community that powers real-world advances using challenging materials like DOPE.
Anyone who has worked with phospholipids in a research setting knows how careless storage can trash months of progress. 1,2-Dioleoyl-sn-Glycero-3-Phosphoethanolamine (often called DOPE in the lab) doesn’t play nice with the environment. Just a little heat or air can turn this high-value phosphoethanolamine into a gooey mess or, worse, leave it completely useless.
Cold storage makes a difference that’s easy to notice. Keeping DOPE in a standard lab fridge leaves it exposed to temperature cycles every time someone grabs lunch or a fresh batch of media. These cycles speed up degradation. I always keep DOPE frozen, preferably at -20°C or lower. Lipids hold up best when they’re shielded from repeated thawing and refreezing. Getting sloppy with freezer handling leads to clumping and a sharp drop in quality. Once you see turbidity or get trouble dissolving your sample, there’s no way back.
DOPE doesn’t just hate the heat. Even dim lighting will start breaking down its double bonds. Keeping it in amber vials blocks most of the harmful light, but I go a step further and wrap containers in foil. As for air exposure, I evacuate all vials with an inert gas before freezing. Oxygen degrades unsaturated lipids fast, and I’ve seen plenty of ruined experiments where someone left a vial open on the benchtop.
Moisture brings headaches in more ways than one. Even a little water encourages hydrolysis. I learned to store open vials in a desiccator, sometimes tossing in fresh silica packs, to keep everything bone-dry. Small steps like these keep DOPE free of sticky clumps and watery residues.
Opening a single stock vial every day chews through shelf life in no time. A better plan: divide your sample into small aliquots from the start. It beats rummaging through a near-empty container and spares your most precious compound the stress of temperature swings and exposure. Aliquoting right after delivery means each portion stays as close to the original quality as possible.
The steep price for this compound won’t tolerate poor record keeping. Every time I take out an aliquot, I jot down how long it sits at room temperature and when it gets used. Labels with open dates and a quick spreadsheet stop mistakes before they turn costly. It just takes a ruined batch or two to become a believer in steady tracking.
There’s always gaps to plug in most chemical storage routines. Investing in small amber vials, working under a nitrogen or argon stream, and setting up backup temperature alarms pay off over time. Even inexpensive steps, like a sturdy dry ice bucket or a set of printed freezer inventories, can help keep essential phospholipids usable.
Researchers know that DOPE is unforgiving but not unmanageable. What counts isn’t just fancy equipment—it’s the daily, sometimes boring habits that make sure a valuable reagent remains ready for use. DOPE lasts longest when it’s kept cold, away from light and oxygen, in small aliquots, and always accounted for.
Every scientist who works with cells, lipids, or drug delivery has felt the challenge of mimicking the living membrane. Lipids play a huge role in how research unfolds, and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (known to many by its shorter name, DOPE) pops up often wherever the work gets real. Looking at cell-like environments, DOPE’s structure comes close to the phosphatidylethanolamine found in most natural membranes. This brings a kind of familiarity to experiments that’s tough to find anywhere else.
Lipid researchers value DOPE for one reason above all: it bends where others break. DOPE forms non-bilayer structures that match the physical shapes and stresses of actual cells much more closely than stiffer lipids do. That’s a big deal in fusion studies, such as those meant to understand how viruses sneak into cells. Without DOPE’s flexibility, the models just don’t behave the same way real membranes do. DOPE’s action as a helper for low-melting transition phases keeps research honest by reflecting what truly happens on a molecular level when two membranes meet.
For many years, drug makers struggled with how to get medicine where it counts. Naked DNA, RNA, and some small molecules degrade or get lost before reaching their target. That changed once scientists mixed DOPE into delivery systems like liposomes and lipid nanoparticles. Take the COVID-19 mRNA vaccines — researchers used similar lipids to ferry genetic material safely inside cells. DOPE encouraged the nanoparticle to fuse with cell membranes and release its cargo at the right spot. Researchers at places like MIT and BioNTech have documented this kind of success in both animal and clinical trials, leading to the breakthroughs that made headlines during the pandemic.
CRISPR’s rise in gene editing also owes some of its speed to DOPE. Scientists often add it to their “recipes” for delivering Cas9 protein and guide RNA into cells. High editing rates followed, because DOPE helps escape from endosomes—little vesicles that can trap the expensive gene editing machinery. Without DOPE, most of these systems would just recycle what’s inside or digest it completely.
Beyond therapeutics, diagnostic tools like liposome-based biosensors lean on DOPE to build accurate, robust sensors for toxins and proteins in human blood or food. DOPE stabilizes artificial vesicles, shapes the sensor, and helps tune responses. Biophysics research dives deep into these systems, too. Labs working with neutron scattering or fluorescence spectroscopy depend on DOPE to help model processes like neurotransmitter release—revealing more about diseases like Parkinson’s and Alzheimer’s.
Getting the most out of DOPE starts with purity and consistency. I’ve seen projects stall because batches varied ever so slightly. Reliable suppliers and shared standards tackle this, and groups like Avanti Polar Lipids focus hard on quality checks. Issues around cost and shelf-life remain, so keeping the material cold and dry helps ensure experiments go as planned. Projects combining DOPE with custom peptides, targeted ligands, or other advanced molecules show huge promise for personalized medicine—a future built on lessons learned from today’s research bench.
1,2-Dioleoyl-sn-Glycero-3-Phosphoethanolamine (DOPE) pops up often in biotech labs. Folks use it for making liposomes, messing with drug delivery, or even fiddling with gene transfer. Most people I’ve seen around the lab hear “lipid” and think “safe.” That’s a lazy trap. Just because it comes from oil doesn’t mean you want it on your skin, in your eyes, or drifting in the air.
DOPE doesn’t scream “toxin” in the way something like benzene does. Still, it’s always smart to check the safety data sheet (SDS) before starting work. The need for gloves and goggles isn’t about drama; touching your face halfway through a project and picking up a weird rash or burning eyes never helped anyone finish an experiment. Dry powder and organic solvent can sneak into your lungs, so a face mask keeps trouble away, especially during weighing or preparing a stock solution.
DOPE doesn’t jump out of a bottle and hurt you, but splashed liquid or inhaled dust can get ugly. A few years ago, I watched a researcher deal with a sneaky splash, and it led to days of irritation—nothing life-threatening, just a miserable reminder to double-check PPE. Chronic exposure studies on DOPE lag behind, so there’s no “safe” record for daily use. Not seeing something on the toxicity list today doesn’t promise you it’s harmless across a career.
Standard gear like nitrile gloves, chemical splash goggles, and a dust mask cut most risks down to size. Any open work stays inside a fume hood. Wipe down benches after use since even tiny lipid droplets can pick up contaminants. I store phospholipids in dark vials, tucked away at -20°C, since heat or sunlight breaks them down and changes how they behave. Spills can get slippery fast, so walk with care.
People forget that even molecules “from nature”—which DOPE is, in some ways—can clog drains or add to wastewater trouble. Never pour lipid residues down the sink. They clump up, block pipes, and cost the building a fortune in fixes. Instead, I collect all used solutions or cleanup in labeled waste for solvent disposal. It matters, especially in a busy lab with students getting their first taste of real research.
SDS entries flag DOPE as irritating to eyes and skin. Use in ventilated spaces and avoid breathing in powder. No robust long-term human toxicity data exists, so smart folks handle it with the same caution they give to other synthetic compounds. The NIH and ECHA keep updating guidelines, but most of the rules circle back to general lab discipline—don’t eat, drink, or touch your face while handling.
Healthy skepticism pays off. I keep an eye on new studies, especially since most research right now looks at acute exposure, not slow, steady absorption through skin or breathing. Teaching students to respect every new chemical—not just the ones with skulls on the label—builds better habits. Even if DOPE feels mild compared to some harsh organics, it asks for respect, not overconfidence. Safer habits don’t just protect your hands, they shield your future work and everyone sharing the space.
| Names | |
| Preferred IUPAC name | (2R)-2,3-bis[(9Z)-octadec-9-enoyloxy]propyl phosphoethanolamine |
| Other names |
DOPE 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine Dioleoyl phosphatidylethanolamine DOPC |
| Pronunciation | /ˌdaɪ.oʊˈleɪ.ɔɪl sn ɡlɪˈsɪə.roʊ θri ˌfɒs.foʊˌɛθ.əˈnəʊ.ləˌmiːn/ |
| Identifiers | |
| CAS Number | ['4004-05-1'] |
| Beilstein Reference | 12390175 |
| ChEBI | CHEBI:60607 |
| ChEMBL | CHEMBL1236692 |
| ChemSpider | 21541184 |
| DrugBank | DB11245 |
| ECHA InfoCard | 03bdeed1-ccfe-4339-86bd-8eedeebab44e |
| EC Number | 206-737-3 |
| Gmelin Reference | 1666733 |
| KEGG | C04230 |
| MeSH | D015272 |
| PubChem CID | 131712 |
| RTECS number | TH7600000 |
| UNII | 2TI53G5876 |
| UN number | UN1993 |
| CompTox Dashboard (EPA) | DTXSID5049296 |
| Properties | |
| Chemical formula | C41H78NO8P |
| Molar mass | 744.049 g/mol |
| Appearance | White solid |
| Odor | Odorless |
| Density | 0.950 g/mL at 25 °C |
| Solubility in water | Insoluble in water |
| log P | 8.95 |
| Vapor pressure | Vapor pressure: <1.0E-11 mmHg (25°C) |
| Acidity (pKa) | 4.9 |
| Basicity (pKb) | 7.5 |
| Magnetic susceptibility (χ) | -7.46 × 10⁻⁶ |
| Refractive index (nD) | 1.474 |
| Viscosity | Viscous oil |
| Dipole moment | 10.1 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 754.3 J/(mol·K) |
| Std enthalpy of combustion (ΔcH⦵298) | -16469.8 kJ/mol |
| Pharmacology | |
| ATC code | A05AB05 |
| Hazards | |
| Main hazards | Causes serious eye irritation. Causes skin irritation. May cause respiratory irritation. |
| GHS labelling | Not a hazardous substance or mixture. |
| Pictograms | GHS07, GHS08 |
| Signal word | Warning |
| Hazard statements | No Hazard Statements |
| Precautionary statements | Precautionary statements: P262-Do not get in eyes, on skin, or on clothing. |
| NFPA 704 (fire diamond) | NFPA 704: "Health: 1, Flammability: 1, Instability: 0, Special: - |
| Flash point | > 271.77 °C |
| NIOSH | TR-63619 |
| PEL (Permissible) | Not Established |
| REL (Recommended) | 100 µg/mL |
| IDLH (Immediate danger) | NIOSH has not established an IDLH value for 1,2-Dioleoyl-sn-Glycero-3-Phosphoethanolamine. |
| Related compounds | |
| Related compounds |
1,2-Dipalmitoyl-sn-Glycero-3-Phosphoethanolamine 1,2-Dioleoyl-sn-Glycero-3-Phosphocholine 1,2-Dioleoyl-sn-Glycero-3-Phospho-L-Serine 1,2-Distearoyl-sn-Glycero-3-Phosphoethanolamine 1,2-Dimyristoyl-sn-Glycero-3-Phosphoethanolamine |
